How can we elicit health workers' preferences for measures to reduce informal payments? A mixed methods approach to developing a discrete choice experiment in Tanzania.

health economics health policy human resource management qualitative research statistics & research methods

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
07 07 2023
Historique:
medline: 10 7 2023
pubmed: 8 7 2023
entrez: 7 7 2023
Statut: epublish

Résumé

While discrete choice experiments (DCEs) have been used in other fields as a means of eliciting respondent preferences, these remain relatively new in studying corrupt practices in the health sector. This study documents and discusses the process of developing a DCE to inform policy measures aimed at addressing informal payments for healthcare in Tanzania. A mixed methods design was used to systematically develop attributes for the DCE. It involved five stages: a scoping literature review, qualitative interviews, a workshop with health providers and managers, expert review and a pilot study. Dar es Salaam and Pwani regions in Tanzania. Health workers and health managers. A large number of factors were identified as driving informal payments in Tanzania and thus represent potential areas for policy intervention. Through iterative process involving different methods (qualitative and quantitative) and seeking consensus views by diverse actors, we derived six attributes for a DCE: mode of payment, supervision at the facility level, opportunity for private practice, awareness and monitoring, disciplinary measures against informal payments and incentive payment for staff if a facility has less informal payments. 12 choice sets were generated and piloted with 15 health workers from 9 health facilities. The pilot study revealed that respondents could easily understand the attributes and levels, answered all the choice sets and appeared to be trading between the attributes. The results from the pilot study had expected signs for all attributes. We elicited attributes and levels for a DCE to identify the acceptability and preferences of potential policy interventions to address informal payments in Tanzania through a mixed-methods approach. We argue that more attention is needed to the process of defining attributes for the DCE, which needs to be rigorous and transparent in order to derive reliable and policy-relevant findings.

Identifiants

pubmed: 37419635
pii: bmjopen-2022-068781
doi: 10.1136/bmjopen-2022-068781
pmc: PMC10335481
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e068781

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Pharmacoeconomics. 2014 Sep;32(9):883-902
pubmed: 25005924
Soc Sci Med. 2016 Mar;152:119-24
pubmed: 26854622
Health Aff (Millwood). 2007 Jul-Aug;26(4):984-97
pubmed: 17630441
Patient. 2019 Feb;12(1):137-148
pubmed: 30367434
BMC Health Serv Res. 2018 Jun 22;18(1):483
pubmed: 29929523
Health Policy. 2011 Feb;99(2):107-15
pubmed: 20709420
J Subst Use. 2016 Nov 1;21(6):662-668
pubmed: 27695386
Appl Health Econ Health Policy. 2003;2(1):55-64
pubmed: 14619274
J Health Serv Res Policy. 2007 Jan;12(1):25-30
pubmed: 17244394
Health Econ. 2012 Jun;21(6):730-41
pubmed: 21557381
BMC Health Serv Res. 2014 May 22;14:235
pubmed: 24884920
Cochrane Database Syst Rev. 2016 Aug 16;(8):CD008856
pubmed: 27528494
Glob Public Health. 2014;9(10):1125-38
pubmed: 25248312
Int J Health Policy Manag. 2020 Jul 01;9(7):286-296
pubmed: 32613800
Health Policy Plan. 2008 Mar;23(2):83-94
pubmed: 18281310
J Health Polit Policy Law. 2006 Apr;31(2):251-93
pubmed: 16638832
Int J Health Policy Manag. 2018 Dec 22;8(4):191-194
pubmed: 31050963
Health Policy Plan. 2009 Mar;24(2):151-8
pubmed: 19112071
Soc Sci Med. 2007 Apr;64(8):1738-53
pubmed: 17257725
Value Health. 2011 Jun;14(4):403-13
pubmed: 21669364
PLoS One. 2015 Aug 28;10(8):e0135013
pubmed: 26317510
Health Res Policy Syst. 2019 Jan 30;17(1):11
pubmed: 30700308
Hum Resour Health. 2009 Jun 30;7:53
pubmed: 19566926
BMC Health Serv Res. 2021 Dec 29;21(1):1367
pubmed: 34965864
Health Aff (Millwood). 2007 Jul-Aug;26(4):962-70
pubmed: 17630438
Pharmacoeconomics. 2008;26(8):661-77
pubmed: 18620460
Qual Health Care. 2001 Sep;10 Suppl 1:i55-60
pubmed: 11533440
Health Econ Rev. 2019 Oct 30;9(1):30
pubmed: 31667632
Health Econ. 2012 Feb;21(2):145-72
pubmed: 22223558
Health Policy Plan. 2019 Sep 1;34(7):529-543
pubmed: 31377775
Health Policy Plan. 2016 Dec;31(10):1467-1478
pubmed: 27190223
Health Policy. 2001 Jul;57(1):1-13
pubmed: 11348690
Med J Islam Repub Iran. 2018 Mar 28;32:26
pubmed: 30159277
Health Econ. 2013 Oct;22(10):1250-71
pubmed: 23188621
Health Policy Plan. 2021 Aug 12;36(7):1036-1044
pubmed: 34021334
BMJ Glob Health. 2021 Jul;6(7):
pubmed: 34326070
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33272939

Auteurs

Peter Binyaruka (P)

Department of Health System, Impact Evaluation and Policy, Ifakara Health Institute, Ifakara, Tanzania pbinyaruka@ihi.or.tz.

Blake Angell (B)

University of New South Wales Sydney, The George Institute for Global Health, Newtown, New South Wales, Australia.

Martin McKee (M)

Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK.

Antonio Andreoni (A)

Department of Economics, SOAS University of London, London, UK.
College of Business and Economics, University of Johannesburg, South African Chair in Industrial Development, Auckland Park, Gauteng, South Africa.

Masuma Mamdani (M)

Department of Health System, Impact Evaluation and Policy, Ifakara Health Institute, Ifakara, Tanzania.

Eleanor Hutchinson (E)

Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK.

Dina Balabanova (D)

Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH